Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Assessment of Ceftazidime in Intermittent Hemodialysis Patients

NCT01507532 is registered in ClinicalTrials.gov with Midwestern University as lead sponsor.

NCT NCT01507532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01507532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Assessment of Ceftazidime in Intermittent Hemodialysis Patients
Lead sponsor
Midwestern University
Phase
Phase 4
Overall status
Withdrawn
Start date
January 31, 2012
Completion date
January 31, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal failure